Japan’s Health Ministry Deems HPV DNA Testing “Unnecessary” In Cervical Cancer Screening Guidelines
This article was originally published in The Pink Sheet Daily
Executive Summary
HPV vaccine makers Merck and GlaxoSmithKline both have applied for marketing approval in Japan, where 7,000 cases of cervical cancer were diagnosed in 2007.